Causes of Horner Syndrome: A Study of 318 Patients.
Journal
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
ISSN: 1536-5166
Titre abrégé: J Neuroophthalmol
Pays: United States
ID NLM: 9431308
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
15
10
2019
medline:
14
7
2021
entrez:
15
10
2019
Statut:
ppublish
Résumé
Some reports have indicated that when a cause for Horner syndrome can be determined, it is most often chest and neck tumors and stroke. Others have suggested that Horner syndrome is more frequently caused by surgical procedures in the neck and chest. These differences may be explained by disparate accrual methods. Therefore, we decided to compare the cause of Horner syndrome in cases where the diagnosis was confirmed by apraclonidine testing conducted by ophthalmologists to cases in which the diagnosis was made entirely on clinical grounds mostly by nonophthalmologists. We applied a new search engine to the inpatient and outpatient electronic medical records text at the University of Michigan Medical Center from 1996 to 2018 for Horner syndrome with and without pharmacologic confirmation through ocular instillation of apraclonidine 0.5%. Among apraclonidine-confirmed cases, 159 met inclusion criteria. Among apraclonidine-unconfirmed cases, more than 2,000 cases were identified, so that we included only the first 159 cases that met inclusion criteria. In these 318 cases, we documented patient demographics, ophthalmologic features, imaging, underlying cause, and whether the cause was discovered before or after the diagnosis of Horner syndrome. In the cohort of 159 apraclonidine-confirmed cases of Horner syndrome, a cause was identified in 97 (61%). Procedures in the neck, chest, skull base, and paraspinal region accounted for most of the identified causes, with cervical carotid dissection the next most common cause. In a cohort of 159 cases of Horner syndrome not tested with apraclonidine because the clinical diagnosis appeared firm, procedures again accounted for the largest percentage, but tumor was the next most common cause. In both groups, when a cause for Horner syndrome could be identified, that cause was nearly always known before Horner syndrome was identified. However, in an important minority of cases, mostly involving carotid dissection or tumor, the identification of Horner syndrome was critical to the discovery of those conditions. The prevalence of causes of Horner syndrome depends on the accrual method. Among pharmacologically-confirmed cases, the cause was often undetermined or due to a preceding neck or chest procedure. Among pharmacologically-unconfirmed cases, a substantial proportion had also been caused by neck and chest procedures, but tumors in that region were also common. When a cause of Horner syndrome was found in both cohorts, it was usually known before Horner syndrome was discovered, making Horner syndrome an afterthought. However, in an important minority of cases where the cause was not yet known, the identification of Horner syndrome was valuable in leading to important diagnoses such as carotid dissection and tumor.
Sections du résumé
BACKGROUND
Some reports have indicated that when a cause for Horner syndrome can be determined, it is most often chest and neck tumors and stroke. Others have suggested that Horner syndrome is more frequently caused by surgical procedures in the neck and chest. These differences may be explained by disparate accrual methods. Therefore, we decided to compare the cause of Horner syndrome in cases where the diagnosis was confirmed by apraclonidine testing conducted by ophthalmologists to cases in which the diagnosis was made entirely on clinical grounds mostly by nonophthalmologists.
METHODS
We applied a new search engine to the inpatient and outpatient electronic medical records text at the University of Michigan Medical Center from 1996 to 2018 for Horner syndrome with and without pharmacologic confirmation through ocular instillation of apraclonidine 0.5%. Among apraclonidine-confirmed cases, 159 met inclusion criteria. Among apraclonidine-unconfirmed cases, more than 2,000 cases were identified, so that we included only the first 159 cases that met inclusion criteria. In these 318 cases, we documented patient demographics, ophthalmologic features, imaging, underlying cause, and whether the cause was discovered before or after the diagnosis of Horner syndrome.
RESULTS
In the cohort of 159 apraclonidine-confirmed cases of Horner syndrome, a cause was identified in 97 (61%). Procedures in the neck, chest, skull base, and paraspinal region accounted for most of the identified causes, with cervical carotid dissection the next most common cause. In a cohort of 159 cases of Horner syndrome not tested with apraclonidine because the clinical diagnosis appeared firm, procedures again accounted for the largest percentage, but tumor was the next most common cause. In both groups, when a cause for Horner syndrome could be identified, that cause was nearly always known before Horner syndrome was identified. However, in an important minority of cases, mostly involving carotid dissection or tumor, the identification of Horner syndrome was critical to the discovery of those conditions.
CONCLUSIONS
The prevalence of causes of Horner syndrome depends on the accrual method. Among pharmacologically-confirmed cases, the cause was often undetermined or due to a preceding neck or chest procedure. Among pharmacologically-unconfirmed cases, a substantial proportion had also been caused by neck and chest procedures, but tumors in that region were also common. When a cause of Horner syndrome was found in both cohorts, it was usually known before Horner syndrome was discovered, making Horner syndrome an afterthought. However, in an important minority of cases where the cause was not yet known, the identification of Horner syndrome was valuable in leading to important diagnoses such as carotid dissection and tumor.
Identifiants
pubmed: 31609831
doi: 10.1097/WNO.0000000000000844
pmc: PMC7148177
mid: NIHMS1041259
pii: 00041327-202009000-00012
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
362-369Subventions
Organisme : NEI NIH HHS
ID : K23 EY027849
Pays : United States
Références
Headache. 2008 Mar;48(3):467-70
pubmed: 18194296
J Neuroophthalmol. 2010 Mar;30(1):1-2
pubmed: 20182196
Neurol Clin. 2017 Feb;35(1):145-151
pubmed: 27886891
Arch Neurol. 1979 Jan;36(1):13-5
pubmed: 420595
Cardiol Rev. 2012 May-Jun;20(3):145-52
pubmed: 22301716
Curr Opin Ophthalmol. 2003 Dec;14(6):357-63
pubmed: 14615640
Can J Ophthalmol. 2015 Apr;50(2):107-11
pubmed: 25863849
AJNR Am J Neuroradiol. 1992 Jan-Feb;13(1):223-7
pubmed: 1595449
Curr Opin Ophthalmol. 2011 Nov;22(6):468-71
pubmed: 21918445
Cephalalgia. 2013 Jul;33(9):629-808
pubmed: 23771276
J Biomed Inform. 2015 Jun;55:290-300
pubmed: 25979153
Arch Neurol. 1982 Feb;39(2):108-11
pubmed: 7059291
J Neuroophthalmol. 2017 Sep;37(3):268-272
pubmed: 28445191
J Neuroophthalmol. 2010 Mar;30(1):7-11
pubmed: 20182199
Am J Ophthalmol. 1980 Sep;90(3):394-402
pubmed: 7425056
Asia Pac J Ophthalmol (Phila). 2012 May-Jun;1(3):175-9
pubmed: 26107336
Am J Ophthalmol. 1958 Sep;46(3 Pt 1):289-96
pubmed: 13571334
Eye (Lond). 2013 Mar;27(3):291-8
pubmed: 23370415
J Neuroophthalmol. 2010 Mar;30(1):70-2
pubmed: 20182213